hydroxide ion: Clinical Trials

5 trials of hydroxide ion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Unknown 1

Follow hydroxide ion: new trials by email Literature Review of hydroxide ion trials Research Report on hydroxide ion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
Carfilzomib delivered in OH only, Carfilzomib delivered in OH and HaH combined - Multiple Myeloma
Not applicableUnknownCentral Hospital, Nancy, France522022-01-012022-01-11
The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals
Pasture-raised whey protein, Conventional whey protein, Placebo - Muscle Damage, Muscle Soreness
Not applicableCompletedIndiana University392021-11-152023-03-02
The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients
Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion - COVID-19, Vitamin D Deficiency
Not applicableCompletedPauls Stradins Clinical University Hospital1022021-02-012022-08-16
To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans
25 Hydroxy- Vitamin D3 [25 (OH) D3], Placebo - Hypovitaminosis D
Not applicableCompletedCharles Drew University of Medicine and Science3302013-09-012019-02-15
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
hygienic information plus 62% ethyl alcohol in emollient gel, hygienic information - Bacterial Vaginosis
Not applicableCompletedUniversity of Washington2232003-06-012007-10-31

Conditions studied

Vitamin D Deficiency (2)  ·  COVID-19 (1)  ·  Multiple Myeloma (1)  ·  Myalgia (1)  ·  Recurrence (1)  ·  Vaginosis, Bacterial (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  Charles Drew University of Medicine and Science (1)  ·  Indiana University (1)  ·  Pauls Stradins Clinical University Hospital (1)  ·  University of Washington (1)

Countries

United States (2)  ·  Kenya (1)  ·  Latvia (1)

Top investigators

David Martins, MD (1)  ·  King K. Holmes, MD, PhD (1)  ·  Timothy D Mickleborough, Ph.D. (1)  ·  Valdis Pirags, MD, PhD (1)

NIH funding

P30AI027757 (1), R03TW005820 (1), U54MD008149 (1)